AINewsnow

AI-Designed Drug Shows Reversal of Aging Markers in Lung Disease Trial

This story is from 2026-09-07. It is preserved in the archive; the latest stories are on the live feed.

Insilico Medicine's machine learning-discovered compound demonstrated measurable rejuvenation effects in human patients, raising questions about AI's role in longevity research. Artificial intelligence has moved beyond theoretical promise into measurable clinical outcomes. An experimental drug desi…

Read the full story at DEV Community — Machine Learning ↗

Timeline · 2 reports

  1. 2026-09-07 18:58 · AI Insider
    AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study
  2. 2026-09-07 17:22 · DEV Community — Machine Learning
    AI-Designed Drug Shows Reversal of Aging Markers in Lung Disease Trial

More stories

  1. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  2. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  3. Alibaba ships Qwen3.8-Omni-Flash to watch, listen and call tools — r/LocalLLM
  4. NVIDIA CEO Jensen Huang rejects ‘AI will end the world’ claim, yet cautions ‘we should go as fast as we can but...’ — Mint AI
  5. Meet the Data Agent in ChatGPT Work — OpenAI YouTube
  6. AI hallucination of Chinese nuclear components almost led to US military attack — Ars Technica AI
  7. TypeSafe AI Releases Jev: A System One Model That Returns Typed, Calibrated Decisions Instead of Text — MarkTechPost
  8. AI's role in building AI surging? Anthropic says Claude now leads 26% of its R&D — Mint AI

Get the daily brief of stories like this at 6:30 every morning →